Antimitotic Agents: all 5,052 studies that test it
Page 24 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.CompletedNCT04247165Phase 1/2
- PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant PatientsStatus unknownNCT04243434Phase 1
- Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical CancerStatus unknownNCT04238988Phase 2
- Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has SpreadActive, not recruitingNCT04233866Phase 2
- Plinabulin iv Solution in Prevention of TAC Induced NeutropeniaCompletedNCT04227990Phase 2
- Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT04225364Phase 2
- Phase II Study of Neoadjuvant Weekly Paclitaxel and Carboplatin Followed by Dose Dense Epirubicin and Cyclophosphamide in Stage II and III Triple Negative Breast CancerCompletedNCT04224922Phase 2
- COlchicine in Cardiac SurgeryCompletedNCT04224545Phase 4
- Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT04221555Phase 2
- Paclitaxel for the Treatment of Gastric or Gastroesophageal CancerActive, not recruitingNCT04220827Phase 1
- Effect of Colchicine in Patients With Myocardial InfarctionWithdrawnNCT04218786Phase 2
- Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer PatientsStatus unknownNCT04217096Phase 4
- Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic CancerStatus unknownNCT04216758Phase 2
- Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung CancerStatus unknownNCT04213937Phase 2
- SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast CancerStatus unknownNCT04213898Phase 1/2
- DCV in the Treatment of Recurrence and Refractory Childhood Solid TumorsStatus unknownNCT04213612Phase 1
- A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial CarcinomaStatus unknownNCT04211012Phase 2
- Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung CancerTerminatedNCT04210037Phase 1/2
- Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast CancerStatus unknownNCT04194684Phase 2
- Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast CancerActive, not recruitingNCT04193059Phase 3
- Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical StudyStatus unknownNCT04190745Phase 2
- Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-CancerCompletedNCT04187898Phase 1
- Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric CancerStatus unknownNCT04182724Phase 1/2
- Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of ColchicineCompletedNCT04181996Phase 3
- SHR- 1210 Combined With Paclitaxel (Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic CancerCompletedNCT04181645Not applicable
- A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer PatientsCompletedNCT04180384Phase 2
- PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric CancerStatus unknownNCT04174339Not applicable
- SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung CancerTerminatedNCT04171284Phase 3
- An Extension Study to Provide Oraxol to Patients Who Completed KX-ORAX-007TerminatedNCT04168957Phase 1
- A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLCStatus unknownNCT04167774Phase 2
- Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot)CompletedNCT04160117Phase 3
- Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic CancerSuspendedNCT04158635Phase 1
- Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLCCompletedNCT04158440Phase 3
- Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerActive, not recruitingNCT04158362Phase 3
- Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal CarcinomaActive, not recruitingNCT04156698Phase 2
- Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin LevelsStatus unknownNCT04155879Not applicable
- POF Versus FOLFOX Plus IP Paclitaxel in AGCStatus unknownNCT04155671Phase 2
- A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric CancerStatus unknownNCT04152889Phase 2
- Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast CancerStatus unknownNCT04152057Phase 1/2
- A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and ChemotherapyWithdrawnNCT04151563Phase 1/2
- A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard ChemotherapyStatus unknownNCT04150575Phase 2
- Neoadjuvant POF in the Treatment of Locally Advanced Gastric CancerStatus unknownNCT04149015Phase 2
- Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast CancerStatus unknownNCT04143906Phase 2
- Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction AdenocarcinomaStatus unknownNCT04140318Phase 2
- Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot StudyWithdrawnNCT04139655Not applicable
- Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric CancerStatus unknownNCT04135781Phase 3
- Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)CompletedNCT04127019Phase 3
- Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic CancerActive, not recruitingNCT04115163Phase 2
- Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract CancersStatus unknownNCT04111380Phase 2
- Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT04095364Phase 3
- Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast CancerActive, not recruitingNCT04083963Phase 2
- A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid TumorActive, not recruitingNCT04078295Phase 1/2
- Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's LymphomaActive, not recruitingNCT04067037Phase 2
- Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.Status unknownNCT04063683Phase 2
- Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant TumorsStatus unknownNCT04060472Phase 2/3
- Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide ChemotherapyStatus unknownNCT04056949Phase 2
- Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.CompletedNCT04056039Phase 2
- A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction CancerCompletedNCT04053205Phase 1/2
- Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)TerminatedNCT04046887Phase 1
- Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal CancerActive, not recruitingNCT04046575Phase 1
- A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid TumorCompletedNCT04046016Early Phase 1
- COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast CancerWithdrawnNCT04038489Phase 2
- Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the ExtremitiesTerminatedNCT04037527Phase 1
- KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast CancerStatus unknownNCT04034823Phase 2
- Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)CompletedNCT04031703Phase 3
- VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical CancerStatus unknownNCT04017377Not applicable
- A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in ChinaActive, not recruitingNCT04015778Phase 2
- Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPCStatus unknownNCT04015661Phase 2
- PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNAActive, not recruitingNCT04015622Phase 2
- Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA VasculitisStatus unknownNCT04008316Phase 3
- Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal CarcinomaCompletedNCT04004871Phase 2
- A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTCStatus unknownNCT04004234Phase 1/2
- PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal CarcinomatosisActive, not recruitingNCT04000906Phase 1
- A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerStatus unknownNCT03997539Phase 2
- Pegylated Liposomal Doxorubicin Plus Albumin-Bound Paclitaxel and Trastuzumab in HER-2 Positive Breast CancerStatus unknownNCT03994107Phase 1/2
- Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaCompletedNCT03991884Phase 1
- Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLCStatus unknownNCT03991403Phase 3
- S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant AscitesStatus unknownNCT03990103Phase 2
- Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLCTerminatedNCT03990077Phase 1
- Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03986528Phase 4
- Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )Status unknownNCT03975270Phase 2
- Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal AdenocarcinomaStatus unknownNCT03966118Phase 2
- Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLCActive, not recruitingNCT03965468Phase 2
- Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast CancerStatus unknownNCT03959397Phase 2
- Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.Status unknownNCT03947242Not applicable
- Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib.CompletedNCT03944304Phase 2
- Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract CancerStatus unknownNCT03943043Phase 1/2
- Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian CancerStatus unknownNCT03942068Phase 2
- Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial CancerActive, not recruitingNCT03935256Phase 2
- A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast CancerStatus unknownNCT03933982Phase 2
- Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout FlareTerminatedNCT03933007Phase 4
- Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast CancerStatus unknownNCT03932526Phase 2
- Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial CancerActive, not recruitingNCT03932409Phase 1
- Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic CancerStatus unknownNCT03929094Phase 2
- Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous AngiosarcomaActive, not recruitingNCT03921008Phase 1/2
- Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory StudyStatus unknownNCT03919253Phase 2
- The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCCStatus unknownNCT03917966Phase 2
- High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03908333Phase 1/2
- Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast CancerStatus unknownNCT03907800Phase 2
- Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal CancerSuspendedNCT03906565Phase 2